Earlier this year, RSB Spine reported a 97 percent sales increase for fiscal year 2010 compared to FY 2009. Its continued sales growth can be attributed to its InterPlate platform, which is a load-bearing spinal implant that allows 1.8 mm of graft loading without stress shielding. The product allows surgeons to select the flush-fit interbody construct they want and to determine how that construct will behave, according to the release.
Read the company news release about RSB Spine’s Q1 financial results.
Read other coverage about device company financial results:
– SANUWAVE Health Reports FY 2010 Revenues of $728K, 10.1% Increase
